Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Status:
RECRUITING
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of angiotensin receptor/neprilysin inhibitors (ARNI) on improving ischemic mitral regurgitation (IMR) in patients with coronary artery disease undergoing isolated coronary artery bypass grafting (CABG) through a randomized controlled clincial trial.
Phase:
PHASE4
Details
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborators:
Chinese Academy of Medical Sciences Chinese Academy of Medical Sciences, Fuwai Hospital
Treatments:
sacubitril and valsartan sodium hydrate drug combination